322 related articles for article (PubMed ID: 15944534)
1. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography.
Tawakol A; Migrino RQ; Hoffmann U; Abbara S; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
J Nucl Cardiol; 2005; 12(3):294-301. PubMed ID: 15944534
[TBL] [Abstract][Full Text] [Related]
2. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology.
Hyafil F; Cornily JC; Rudd JH; Machac J; Feldman LJ; Fayad ZA
J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582
[TBL] [Abstract][Full Text] [Related]
3. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
[TBL] [Abstract][Full Text] [Related]
4. The atherosclerotic plaque: a healthy challenge to the limits of nuclear imaging.
Bengel FM
J Nucl Cardiol; 2005; 12(3):255-7. PubMed ID: 15944528
[No Abstract] [Full Text] [Related]
5. Positron emission tomography measurement of periodontal 18F-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation.
Fifer KM; Qadir S; Subramanian S; Vijayakumar J; Figueroa AL; Truong QA; Hoffmann U; Brady TJ; Tawakol A
J Am Coll Cardiol; 2011 Feb; 57(8):971-6. PubMed ID: 21329844
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging.
Vucic E; Dickson SD; Calcagno C; Rudd JH; Moshier E; Hayashi K; Mounessa JS; Roytman M; Moon MJ; Lin J; Tsimikas S; Fisher EA; Nicolay K; Fuster V; Fayad ZA
JACC Cardiovasc Imaging; 2011 Oct; 4(10):1100-9. PubMed ID: 21999870
[TBL] [Abstract][Full Text] [Related]
7. [The value of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) in evaluating the stability of atherosclerotic plaques].
Zhang YH; Tian P; Xu JP; Wang ZZ; Zhao XZ; Nie MX; Zhang MD; Zhao QM; Zhao BT; Song SJ
Zhonghua Nei Ke Za Zhi; 2019 Nov; 58(11):808-813. PubMed ID: 31665855
[No Abstract] [Full Text] [Related]
8. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
Tawakol A; Migrino RQ; Bashian GG; Bedri S; Vermylen D; Cury RC; Yates D; LaMuraglia GM; Furie K; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
J Am Coll Cardiol; 2006 Nov; 48(9):1818-24. PubMed ID: 17084256
[TBL] [Abstract][Full Text] [Related]
9. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study.
Ogawa M; Ishino S; Mukai T; Asano D; Teramoto N; Watabe H; Kudomi N; Shiomi M; Magata Y; Iida H; Saji H
J Nucl Med; 2004 Jul; 45(7):1245-50. PubMed ID: 15235073
[TBL] [Abstract][Full Text] [Related]
10. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner.
Millon A; Dickson SD; Klink A; Izquierdo-Garcia D; Bini J; Lancelot E; Ballet S; Robert P; Mateo de Castro J; Corot C; Fayad ZA
Atherosclerosis; 2013 Jun; 228(2):339-45. PubMed ID: 23582588
[TBL] [Abstract][Full Text] [Related]
11. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
[TBL] [Abstract][Full Text] [Related]
12. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.
Ogawa M; Magata Y; Kato T; Hatano K; Ishino S; Mukai T; Shiomi M; Ito K; Saji H
J Nucl Med; 2006 Nov; 47(11):1845-50. PubMed ID: 17079818
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis.
Davies JR; Izquierdo-Garcia D; Rudd JH; Figg N; Richards HK; Bird JL; Aigbirhio FI; Davenport AP; Weissberg PL; Fryer TD; Warburton EA
Int J Cardiovasc Imaging; 2010 Jan; 26(1):41-8. PubMed ID: 19784796
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.
Ben-Haim S; Kupzov E; Tamir A; Israel O
J Nucl Med; 2004 Nov; 45(11):1816-21. PubMed ID: 15534049
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography.
Aziz K; Berger K; Claycombe K; Huang R; Patel R; Abela GS
Circulation; 2008 Apr; 117(16):2061-70. PubMed ID: 18391115
[TBL] [Abstract][Full Text] [Related]
16. Detection of inflamed atherosclerotic lesions with diadenosine-5',5'''-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography.
Elmaleh DR; Fischman AJ; Tawakol A; Zhu A; Shoup TM; Hoffmann U; Brownell AL; Zamecnik PC
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15992-6. PubMed ID: 17038498
[TBL] [Abstract][Full Text] [Related]
17. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG).
Lederman RJ; Raylman RR; Fisher SJ; Kison PV; San H; Nabel EG; Wahl RL
Nucl Med Commun; 2001 Jul; 22(7):747-53. PubMed ID: 11453046
[TBL] [Abstract][Full Text] [Related]
18. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
Mehta NN; Torigian DA; Gelfand JM; Saboury B; Alavi A
J Vis Exp; 2012 May; (63):e3777. PubMed ID: 22588186
[TBL] [Abstract][Full Text] [Related]
19. Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer
Hyafil F; Pelisek J; Laitinen I; Schottelius M; Mohring M; Döring Y; van der Vorst EP; Kallmayer M; Steiger K; Poschenrieder A; Notni J; Fischer J; Baumgartner C; Rischpler C; Nekolla SG; Weber C; Eckstein HH; Wester HJ; Schwaiger M
J Nucl Med; 2017 Mar; 58(3):499-506. PubMed ID: 27789718
[No Abstract] [Full Text] [Related]
20. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
Jezovnik MK; Zidar N; Lezaic L; Gersak B; Poredos P
Inflammation; 2014 Apr; 37(2):426-34. PubMed ID: 24282108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
